2 dividend growth stocks that could be millionaire-makers

Rising dividends could push the valuations of these two stocks higher.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Buying shares in companies with the potential to deliver fast-rising dividends could be a shrewd investment strategy. Inflation has increased to 2.9% and is forecast to move higher. This could increase demand for stocks with brisk dividend growth rates.

Furthermore, increasing dividends indicate management confidence in the company’s long-term future. Given the uncertainty present in the UK economic outlook, this could positively catalyse investor sentiment over the medium term.

With the above in mind, here are two shares which could be worth buying due to their positive income outlooks.

Improving performance

Reporting on Thursday was pharmaceuticals and services company Clinigen (LSE: CLIN). Its full-year results showed a rise in adjusted gross profit of 22%, with the company’s organic growth strategy and acquisition activity both proving to be positive catalysts. Cash flow generation was strong, with cash generated from operations rising by 11%. This allowed the company to pay a dividend which was 25% up on the previous year.

Looking ahead, the company has significant growth potential. Its business units all performed well in the most recent year, with it enjoying particularly strong growth in Africa and Asia Pacific. Its strategy to build scale and efficiency should be enhanced by the post-period end acquisition of Quantum Pharma for £150.3m. This could provide a further boost to its profitability in future years.

While Clinigen has a dividend yield of just 0.5% at the present time, its shareholder payouts are covered nine times by profit. This suggests there could be significant dividend growth ahead for the business. As it matures as a company, a greater proportion of profit is likely to be returned to its investors. This could not only boost income returns, but also signal confidence in the company’s outlook, thereby providing a strong total return in future years.

Growth potential

Also offering high dividend growth prospects is Clipper Logistics (LSE: CLG). The company’s two segments, value-added logistics and commercial vehicles, could offer upbeat earnings growth potential. In fact, the business is forecast to record a rise in its bottom line of 31% in the current year, followed by further growth of 21% next year.

Despite this positive outlook, it trades on a price-to-earnings growth (PEG) ratio of just 1. This suggests that its shares could move higher after their 7% rise in the last six months. And with the company having an excellent track record of profit growth following three years of consecutive double-digit growth, it may be worthy of a much higher valuation premium.

With Clipper Logistics having a dividend yield of 2.2%, it may not appear to be an attractive income play at the present time. However, dividend payments are expected to rise by 18% next year and even then, they are due to be covered almost twice by profit. This suggests that further double-digit dividend growth could be ahead for the company’s investors.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Peter Stephens owns shares in Clinigen. The Motley Fool UK has recommended Clinigen. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Person holding magnifying glass over important document, reading the small print
Investing Articles

Just released: our top 3 small-cap stocks to consider buying in October [PREMIUM PICKS]

Small-cap shares tend to be more volatile than larger companies, so we suggest investors should look to build up a…

Read more »

Investing Articles

How I’d use an empty Stocks and Shares ISA to aim for a £1,000 monthly passive income

Here's how using a Stocks and Shares ISA really could help those of us who plan to invest for an…

Read more »

Investing Articles

This FTSE stock is up 20% and set for its best day ever! Time to buy?

This Fool takes a look at the half-year results from Burberry (LON:BRBY) to see if the struggling FTSE stock might…

Read more »

Investing Articles

This latest FTSE 100 dip could be an unmissable opportunity to pick up cut-price stocks

The FTSE 100 has pulled back with the government’s policy choices creating some negative sentiment. But this gives us a…

Read more »

A young woman sitting on a couch looking at a book in a quiet library space.
Investing Articles

As the WH Smith share price falls 4% on annual results, is it still worth considering?

WH Smith took a hit after this morning’s results left shareholders unimpressed. With the share price down 4%, Mark Hartley…

Read more »

Investing Articles

The Aviva share price just jumped 4.5% but still yields 7.02%! Time to buy?

A positive set of results has put fresh life into the Aviva share price. Harvey Jones says it offers bags…

Read more »

Investing Articles

Can a €500m buyback kickstart the Vodafone share price?

The Vodafone share price has been a loser for investors in recent years, and the dividend has been cut. We…

Read more »

Frustrated young white male looking disconsolate while sat on his sofa holding a beer
Growth Shares

3 mistakes I now avoid when choosing which growth stocks to buy

Jon Smith runs through some of the lessons he's learnt the hard way over the years about what to look…

Read more »